Artificial corneas: A regenerative medicine approach

Eye

Volumn 23, Issue 10, 2009, Pages 1985-1989

  Griffith, M ^a,b   Jackson, W B ^a   Lagali, N ^a,c   Merrett, K ^a,b   Li, F ^a   Fagerholm, P ^c  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Corneal substitutes; Regeneratio; Transplantation

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; CORNEA CELL; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA STROMA; CORNEA TRANSPLANTATION; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; KERATITIS; KERATOCONUS; KERATOPLASTY; KERATOPROSTHESIS; NERVE REGENERATION; NONHUMAN; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TREATMENT INDICATION;

ADULT; AGED; ARTIFICIAL ORGANS; BIOMEDICAL ENGINEERING; CORNEA; CORNEAL TRANSPLANTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; REGENERATIVE MEDICINE; TISSUE ENGINEERING; YOUNG ADULT;

EID: 70350161608     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.409     Document Type: Conference Paper

References (33)

1. Nishida T. Fundamentals of cornea and external disease. In: Krachmer JJ, Mannis MJ, Holland EJ (eds). Cornea. Mosby- Year Book Inc.: St Louis, 1997, pp 3-26.
2. Freegard TJ. The physical basis of transparency of the normal cornea. Eye 1997; 11(Part 4): 465-471.
3. Meller D, Peters K, Meller K. Human cornea and sclera studied by atomic force microscopy. Cell Tissue Res 1997; 288: 111-118.
4. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol 1990; 48: 191-226.
5. Griffith M, Fagerholm P, Liu W, McLaughlin CR, Li F. Corneal regenerative medicine: corneal substitutes for transplantation. In: Reinhard T, Larkin F (eds). Cornea and External Eye Disease, Essentials in Ophthalmology. Heidelberg, 2008, pp 37-53.
6. Myung D, Duhamel PE, Cochran JR, Noolandi J, Ta CN, Frank CW. Development of hydrogel-based keratoprostheses: a materials perspective. Biotechnol Prog 2008; 24: 735-741.
7. Sheardown H, Griffith M. Regenerative medicine in the cornea. In: Atala A, Lanza R, Thompson J, Nerem R (eds). Principles of Regenerative Medicine. Elsevier: Boston, 2008, pp 1060-1071.
8. McLaughlin CR, Tsai RJ-F, Latorre MA, Griffith M. Bioengineered corneas for transplantation and in vitro toxicology. Front Biol Sci (Tissue Eng Issue) (in press).
9. Myung D, Koh W, Ko J, Noolandi J, Carrasco M, Smith A et al. Characterization of poly(ethylene glycol)-poly(acrylic acid) (PEG-PAA) double networks designed for corneal implant applications. Invest Ophthalmol Vis Sci 2005; 46: E-Abstract 5003.
10. Jacob JT, Rochefort JR, Bi J, Gebhardt BM. Corneal epithelial cell growth over tethered-protein/peptide surface-modified hydrogels. J Biomed Mater Res B Appl Biomater 2005; 72: 198-205.
11. Bakri A, Farooqui N, Myung D, Koh WG, Noolandi J, Carrasco M et al. Biocompatibility of a Hydrogel Corneal inlay in vivo. Invest Ophthalmol Vis Sci (Arvo Annual Meeting) 2006; 47 [e-pub ahead of print; abstract no. abstract 3592].
12. Sweeney DF, Xie RZ, OLeary DJ, Vannas A, Odell R, Schindhelm K et al. Nutritional requirements of the corneal epithelium and anterior stroma: clinical findings. Invest Ophthalmol Vis Sci 1998; 39: 284-291.
13. Gaudreault M, Carrier P, Larouche K, Leclerc S, Giasson M, Germain L et al. Influence of sp1/sp3 expression on corneal epithelial cells proliferation and differentiation properties in reconstructed tissues. Invest Ophthalmol Vis Sci 2003; 44: 1447-1457.
14. Carrier P, Deschambeault A, Talbot M, Giasson CJ, Auger FA, Guerin SL et al. Characterization of wound reepithelialization using a new human tissue-engineered corneal wound-healing model. Invest Ophthalmol Vis Sci 2008; 49: 1376-1385.
15. Guo X, Hutcheon AE, Melotti SA, Zieske JD, Trinkaus- Randall V, Ruberti JW. Morphologic characterization of organized extracellular matrix deposition by ascorbic acidstimulated human corneal fibroblasts. Invest Ophthalmol Vis Sci 2007; 48: 4050-4060.
16. Meek KM, Leonard DW. Ultrastructure of the corneal stroma: a comparative study. Biophys J 1993; 64: 273-280.
17. Du Y, Funderburgh ML, Mann MM, SundarRaj N, Funderburgh JL. Multipotent stem cells in human corneal stroma. Stem Cells 2005; 23: 1266-1275.
18. Du Y, Sundarraj N, Funderburgh ML, Harvey SA, Birk DE, Funderburgh JL. Secretion and organization of a cornea-like tissue in vitro by stem cells from human corneal stroma. Invest Ophthalmol Vis Sci 2007; 48: 5038-5045.
19. Borene ML, Barocas VH, Hubel A. Mechanical and cellular changes during compaction of a collagen-sponge-based corneal stromal equivalent. Ann Biomed Eng 2004; 32: 274-283.
20. Crabb RA, Chau EP, Evans MC, Barocas VH, Hubel A. Biomechanical and microstructural characteristics of a collagen film-based corneal stroma equivalent. Tissue Eng 2006; 12: 1565-1575.
21. Merrett K, Fagerholm P, McLaughlin CR, Dravida S, Lagali NS, Shinozaki N et al. Tissue engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen. Invest Ophthalmol Vis Sci 2008; 49: 3887-3894.
22. Liu W, Merrett K, Griffith M, Fagerholm P, Dravida S, Heyne B et al. Recombinant human collagen for tissue engineered corneal substitutes. Biomaterials 2008; 29: 1147-1158.
23. Fagerholm P, Lagali N, Carlsson DJ, Merret K, Griffith M. Corneal regeneration following implantation of a biomimetic tissue-engineered substitute. Clin Transl Sci (in press).
24. Li F, Carlsson D, Lohmann C, Suuronen E, Vascotto S, Kobuch K et al. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci USA 2003; 100: 15346-15351.
25. Liu W, Griffith M, Li F. Alginate microsphere-collagen composite hydrogels for ocular drug delivery and implantation. J Mater Sci Mater Med 2008; 19: 3365-3371.
26. Liu W, Deng C, McLaughlin CR, Fagerholm P, Watsky MA, Heyne B et al. Collagen-phosphorylcholine interpenetrating network hydrogels as corneal substitutes. Biomaterials 2008; available online 20 December 2008, doi:10.1016/j.biomaterials. 2008.11.022.
27. Nakamura T, Inatomi T, Sotozono C, Ang LP, Koizumi N, Yokoi N et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease. Ophthalmology 2006; 113: 1765-1772.
28. Rama P, Bonini S, Lambiase A, Golisano O, Paterna P, De Luca M et al. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 2001; 72: 1478-1485.
29. Dravida S, Gaddipati S, Griffith M, Merrett K, Lakshmi Madhira S, Sangwan VS et al. A biomimetic scaffold for culturing limbal stem cells: a promising alternative for clinical transplantation. J Tissue Eng Regen Med 2008; 2: 263-271.
30. Inatomi T, Nakamura T, Kojyo M, Koizumi N, Sotozono C, Kinoshita S. Ocular surface reconstruction with combination of cultivated autologous oral mucosal epithelial transplantation and penetrating keratoplasty. Am J Ophthalmol 2006; 142: 757-764.
31. Hsiue GH, Lai JY, Chen KH, Hsu WM. A novel strategy for corneal endothelial reconstruction with a bioengineered cell sheet. Transplantation 2006; 81: 473-476.
32. Griffith M, Osborne R, Munger R, Xiong X, Doillon C, Laycock NLC et al. Functional human corneal equivalents from cell lines. Science 1999; 286: 2169-2172.
33. Vrana NE, , Builles N, Justin V, Bednarz J, Pellegrini G, Ferrari B et al. Development of a reconstructed cornea from collagen-chondroitin sulfate foams and human cell cultures. Invest Ophthalmol Vis Sci 2008; 49: 5325-5331.